These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 9533847

  • 1. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S, Mori K, Wyman M, Kador PF.
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF, Betts D, Wyman M, Blessing K, Randazzo J.
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [Abstract] [Full Text] [Related]

  • 4. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M, Fukui H, Kuwabara T, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N, Tsui J, Johnson M.
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG, Laver NM, Jacot JL, Glover JP.
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
    Teshima R, Taura T, Okamura R.
    Jpn J Ophthalmol; 1991 Nov; 35(3):317-24. PubMed ID: 1770672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R, Taura T, Okamura R.
    Jpn J Ophthalmol; 1993 Nov; 37(2):192-8. PubMed ID: 8230845
    [Abstract] [Full Text] [Related]

  • 15. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs.
    Cusick M, Chew EY, Ferris F, Cox TA, Chan CC, Kador PF.
    Arch Ophthalmol; 2003 Dec; 121(12):1745-51. PubMed ID: 14662595
    [Abstract] [Full Text] [Related]

  • 16. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ, Harris R, Brightman A, McGill J, Hua D, Davidson H, Fenwick B, Wagner LM.
    Vet Ophthalmol; 2004 Dec; 7(3):163-7. PubMed ID: 15091323
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS, Kim J, Lee YM, Sohn E, Jo K, Kim JS.
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [Abstract] [Full Text] [Related]

  • 18. Cataract formation through the polyol pathway is associated with free radical production.
    Kubo E, Miyoshi N, Fukuda M, Akagi Y.
    Exp Eye Res; 1999 Apr; 68(4):457-64. PubMed ID: 10192803
    [Abstract] [Full Text] [Related]

  • 19. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [Abstract] [Full Text] [Related]

  • 20. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
    Kador PF, Randazzo J, Babb T, Koushik K, Takamura Y, Zhu W, Blessing K, Kompella UB.
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.